Dinish et al. [73] performed actively targeted multiplex in vitro and in vivo detection of three intrinsic cancer biomarkers, EGFR, CD44 and TGF beta-receptor II (TGFbRII), in a breast cancer model using three multiplexing capable and biocompatible SERS. The gene discussed is EGFR; the disease is breast carcinoma.